NCT03095508 - Clinical Study for Comparative Assessment of Efficacy and Safety of Angal S, Topical Spray and ANTI-ANGIN® FORMULA, Topical Metered Spray in Treatment of Patients With Uncomplicated Acute Infectious and Inflammatory Diseases of the Pharynx, Accompanied by a Sore Throat | Biotech Hunter

Enrollment

229

Participants

Timeline

Start Date

February 22, 2017

Primary Completion Date

May 8, 2017

Study Completion Date

May 8, 2017

Conditions

Sore Throat

Interventions

DRUG

Angal S, topical spray [Menthol]

0,5 mg + 2 mg (Sandoz d.d., Slovenia), administered as three to five consecutive presses on the actuator button, 6-10 times per day, for a maximum 4 days or until full illness resolution

DRUG

ANTI-ANGIN® FORMULA, topical metered spray

"0,12 mg + 0,24 mg (LLC Valeant, Russia) administered as one to two consecutive presses on the actuator button, up to 6 times per day, , for a maximum 5 days or until full illness resolution"

Trial Locations (14)

105018

Sandoz Investigational Site, Moscow

115280

Sandoz Investigational Site, Moscow

119192

Sandoz Investigational Site, Moscow

127015

Sandoz Investigational Site, Moscow

135215

Sandoz Investigational Site, Moscow